SMA, Biogen and EMA
Biogen Trims Research Workforce, Higher-Dose SMA Drug Accepted for Regulatory Review
In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of its Ionis-partnered therapy Spinraza for spinal muscular atrophy will be considered by the FDA and EMA.
The Cool Down on MSN14d
Explosive allegations could force major mining company to close operations — here's why regulatory officials are worriedThe SAP, the Environmental Protection Agency, the U.S. Fish and Wildlife Service, the United Nations Environment Programme, ...
Dollar Tree, Inc. DLTR is trading above its 50-day simple moving average (SMA), signaling a bullish trend. The company is ...
The spin out of railway technology became legally effective on the 6th of June 2008 after the new company was entered into the trade register. RAIL NETWORK POWER ELECTRONIC COMPONENTS AND SYSTEMS ...
SMA Solar Technology plans to cut up to 1,100 jobs worldwide and lowered forecasts for the year, the German solar power parts supplier said on Wednesday, nearly two months after it announced a ...
Zacks.com on MSN14d
HMN Stock Trades Below 50-Day SMA: What Should You Do Now?Horace Mann Educators Corporation HMN has been trading below its 50-day simple moving average (SMA), signaling a short-term bearish ... HMN is the largest multiline financial services company ...
Petco Health and Wellness Company Inc (WOOF) stock saw a modest uptick, ending the day at $3.87 which represents a slight increase of $0.22 or 6.03% from the prior close of $3.65. The stock opened at ...
We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback